
Quidel Corporation Market Cap 2011-2026 | QDEL
As of February 02, 2026 Quidel Corporation has a market cap of $ 1.15 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Quidel Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 10.6 B | 3.27 B | 2.13 B | 1.58 B | 611 M | 581 M | 811 M | 1.03 B | 740 M | 479 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.6 B | 479 M | 2.18 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Anixa Biosciences
ANIX
|
104 K | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
240 M | $ 23.35 | -2.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 34.5 | 2.16 % | $ 371 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
3.55 M | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
34.9 M | - | - | $ 79.8 M | ||
|
Castle Biosciences
CSTL
|
709 M | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Danaher Corporation
DHR
|
152 B | $ 219.29 | -0.08 % | $ 160 B | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
48.8 B | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
521 M | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
399 M | $ 109.48 | -2.35 % | $ 4.32 B | ||
|
Exact Sciences Corporation
EXAS
|
9.32 B | $ 102.41 | 0.1 % | $ 19 B | ||
|
DarioHealth Corp.
DRIO
|
43.4 M | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 26.19 | -0.19 % | $ 792 M | ||
|
Guardant Health
GH
|
5.84 B | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
IDEXX Laboratories
IDXX
|
37.7 B | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Illumina
ILMN
|
16.4 B | $ 144.81 | -3.26 % | $ 23 B | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
35.7 B | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
8.54 B | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Lantheus Holdings
LNTH
|
6.47 B | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Biodesix
BDSX
|
92.1 M | $ 10.11 | 4.66 % | $ 1.31 B | ||
|
Precipio
PRPO
|
8.7 M | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
21.1 B | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 181.44 | -2.39 % | $ 15 B | ||
|
Medpace Holdings
MEDP
|
10.2 B | $ 582.66 | -1.76 % | $ 18 B | ||
|
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 28.66 | -2.02 % | $ 20 B | ||
|
Agilent Technologies
A
|
42 B | $ 133.33 | 0.07 % | $ 40.5 B | ||
|
Biomerica
BMRA
|
7.19 M | $ 2.41 | 0.84 % | $ 5.54 M | ||
|
OpGen
OPGN
|
9.12 M | - | -16.95 % | $ 1.54 M | ||
|
Bioventus
BVS
|
351 M | $ 7.86 | 0.51 % | $ 492 M | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K |